Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 – A National Cohort Study
Journal of Clinical Immunology · 2024-08 · 44 (6)
DOI: 10.1007/s10875-024-01748-z ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Immunology, online erschienen am 03.06.2024. Verfasst von Sini M Laakso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. sini.m.laakso@helsinki.fi. Hauptthemen laut MEDLINE: Polyendocrinopathies, Autoimmune, Autoantibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Helsinki.
Abstract (Originalsprache)
Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare monogenic disease caused by mutations in the autoimmune regulator gene. Although the disease-associated autoantibodies mostly target endocrine organs, autoantibodies from patients with APS-1 bind also to rat brain structures. The patients often have GAD65-antibodies, that can cause autoimmune encephalitis. However, neurological manifestations of APS-1 have not been systematically explored. We conducted a retrospective chart review on 44 Finnish patients with APS-1 (median age 38 years, 61% females) and collected all their neurological diagnoses. To assess the prevalence of serum antineuronal antibodies in APS-1, serum samples of 24 patients (median age 36 years, 63% females) were analyzed using a fixed cell-based assay. Of the 44 APS-1 patients, 10 (23%) had also received a diagnosis of a neurological disease. Of these neurological comorbidities, migraine ( n = 7; 16%), central nervous system infections ( n = 3; 7%), and epilepsy ( n = 2; 5%) were the most prevalent. Other diagnoses recorded for single patients were axonal sensorimotor polyneuropathy, essential tremor, idiopathic intracranial hypertension, ischemic stroke, and trigeminal neuralgia. Serum antineuronal antibodies were detected in 42% of patients tested (10/24, 50% females, median age 42 years), GAD65 antibodies being the most common finding. Antibodies against glycine and aquaporin 4 were found in low titers. In four patients, relatively high titers of GAD65 antibodies without coexisting type 1 diabetes were found, but none presented with GAD65-encephalitis. Our study suggests an association between APS-1 and neurological disorders, the mechanisms of which are to be further investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. sini.m.laakso@helsinki.fi.
- Brain Center, Helsinki University Hospital, Helsinki, Finland. sini.m.laakso@helsinki.fi.
- Children's Hospital and Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
- Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Folkhälsan Research Center, Helsinki, Finland.
- Department of Molecular Medicine and Surgery, Karolinska Institutet and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Sini M Laakso
Förderung
- University of Helsinki
Zitieren
APA
Laakso, S. M., Häkkinen, A., Mäkitie, O., & Laakso, S. (2024). Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 – A National Cohort Study. Journal of Clinical Immunology, 44(6). https://doi.org/10.1007/s10875-024-01748-z
Vancouver
Laakso SM, Häkkinen A, Mäkitie O, Laakso S. Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 – A National Cohort Study. Journal of Clinical Immunology. 2024;44(6). doi:10.1007/s10875-024-01748-z
BibTeX
@article{Laakso2024,
author = {Laakso, Sini M and Häkkinen, Aino and Mäkitie, Outi and Laakso, Saila},
title = {Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 – A National Cohort Study},
journal = {Journal of Clinical Immunology},
year = {2024},
volume = {44},
number = {6},
doi = {10.1007/s10875-024-01748-z}
}
EUVIMED